CORT — CORCEPT THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying CORT?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 4 tracked investors who changed their CORT position last quarter, 2 bought and 2 sold (50% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).
- +2 tracked investors added or increased positions last quarter (Izzy Englander, Ray Dalio)
- +5 tracked investors reported holding CORT at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- −2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $52M. Across recent filings, tracked investors recorded 6 new positions, 2 increased, 9 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CORT
How many top investors track CORT
A small number of top investors own this.
CORT Ownership Composition
How CORCEPT THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant88.7%
- Macro11.3%
Tracked investors currently reporting CORT
- Izzy EnglanderJun 30, 2026Millennium ManagementShares216.2KValue$18.8M% Portfolio0.01%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares425.7KValue$37M% Portfolio0.00%
- Ray DalioJun 30, 2026Bridgewater AssociatesShares57.6KValue$5M% Portfolio0.02%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares10.1KValue$878.2K% Portfolio0.00%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares25.2KValue$2.2M% Portfolio0.00%
Recent activity
- Reduced$19.8M(-43.34%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $51.5MMay 15, 2025
- Reduced$19.1M(-42.22%)Aug 14, 2025
- $18.8MAug 14, 2026
- New$25.4MNov 13, 2025
- Reduced$9.7M(-8.81%)Feb 13, 2026
- Reduced$1.5M(-86.23%)May 15, 2026
- Increased$5M(49.92%)Aug 14, 2026
- New$25.2MFeb 14, 2025
- Sold$0(-100.00%)Jul 21, 2025
- New$2.3MMay 15, 2026
- Reduced$878.2K(-82.02%)Aug 14, 2026
- $3MFeb 14, 2025
- Reduced$902.3K(-86.87%)May 15, 2025
- Reduced$293.6K(-49.37%)Aug 14, 2025
- Reduced$249.3K(-25.00%)Dec 9, 2025
- Increased$2.2M(669.89%)May 15, 2026
- Reduced$2.2M(-53.69%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold CORT?
- 5 tracked institutional investors disclosed a position in CORT (CORCEPT THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of CORT?
- Izzy Englander, Millennium Management, holds the largest disclosed position in CORT, valued at $52M.
- Did institutional ownership of CORT increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 2 increased, 9 reduced, and 2 fully exited CORT.
- Where does this CORT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.